Local Novartis employees await word on layoffs
Swiss drug maker targeting research positions
Cambridge employees of Swiss drug maker Novartis AG are waiting to find out how a global restructuring - including 2,000 planned job cuts in the United States and Switzerland - will affect company operations in the Boston area. Novartis will save $200 million annually by shedding jobs in research and development, clinical trial monitoring, and other fields on both sides of the Atlantic. The company said it would eliminate 1,100 positions in Switzerland and 900 in the US.
For more from BostonGlobe.com, sign up or log in below
To continue, please sign up or log in to BostonGlobe.com
Access the full articles and quality reporting of The Boston Globe at BostonGlobe.com
Sign up
Unlimited Access to BostonGlobe.com for 4 weeks for only 99¢.
Are you a Boston Globe home delivery subscriber?
Get FREE access as part of your print subscription.
BostonGlobe.com subscriber
Click to continue reading this article or to log in to BostonGlobe.com.
Waiting for Twitter to feed in the latest...